Joshua Reed
Chief Financial Officer
CFO
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Alkermes plc. (ALKS) | Senior Vice President, Chief Financial Officer | $181,978 | $3,797,074 |
| 2021 | Aldeyra Therapeutics, Inc. (ALDX) | Chief Financial Officer | $432,143 | $1,848,134 |
| 2020 | Aldeyra Therapeutics, Inc. (ALDX) | Chief Financial Officer | $382,143 | $1,688,894 |
| 2019 | Aldeyra Therapeutics, Inc. (ALDX) | Chief Financial Officer | $377,000 | $2,181,275 |
Executive changes
Earnings-call appearances
-
Alkermes plc. Q1 FY2026 Earnings Call2026-05-05
Alkermes plc. (ALKS)
-
Alkermes plc. Q4 FY2025 Earnings Call2026-02-25
Alkermes plc. (ALKS)
-
Alkermes plc. Q3 FY2025 Earnings Call2025-10-22
Alkermes plc. (ALKS)
-
Aldeyra Therapeutics, Inc. Q1 FY2022 Earnings Call2022-05-05
Aldeyra Therapeutics, Inc. (ALDX)
-
Aldeyra Therapeutics, Inc. Q4 FY2021 Earnings Call2022-03-17
Aldeyra Therapeutics, Inc. (ALDX)
-
Aldeyra Therapeutics, Inc. Q3 FY2021 Earnings Call2021-10-28
Aldeyra Therapeutics, Inc. (ALDX)
-
Aldeyra Therapeutics, Inc. Q2 FY2021 Earnings Call2021-08-05
Aldeyra Therapeutics, Inc. (ALDX)
-
Aldeyra Therapeutics, Inc. Q1 FY2021 Earnings Call2021-05-06
Aldeyra Therapeutics, Inc. (ALDX)
-
Aldeyra Therapeutics, Inc. Q4 FY2020 Earnings Call2021-03-11
Aldeyra Therapeutics, Inc. (ALDX)
-
Aldeyra Therapeutics, Inc. Q3 FY2020 Earnings Call2020-11-05
Aldeyra Therapeutics, Inc. (ALDX)
-
Aldeyra Therapeutics, Inc. Q2 FY2020 Earnings Call2020-08-06
Aldeyra Therapeutics, Inc. (ALDX)
-
Aldeyra Therapeutics, Inc. Q1 FY2020 Earnings Call2020-05-07
Aldeyra Therapeutics, Inc. (ALDX)